Fritextsökning
Innehållstyper
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Unga forskare prisas
Upptäckt koppling mellan tarmfloran och fetma belönas när pris för unga forskare delas ut i Stockholm.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Grönländsk genvariant påverkar diabetes
Andelenfall av typ 2-diabetes på Grönland har ökat dramatiskt de 25 senaste åren. En del av förklaringen ligger i generna. Det visar Niels Grarups forskning och...
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Sales Representative, Applied Biosystems
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
BMS satsar på mer samarbete – inrättar ny funktion
Mer innovativa samarbeten och partnerskap är framtiden inom life science-sektorn, och för att främja det inrättar nu Bristol Myers Squibb, BMS, en helt ny funkt...
-
Han tar plats i Lipums styrelse
Ledde utvecklingen av Lipums huvudkandidat på Scilifelab.
-
Fullt upp för konsultföretag när nya medtechregler införs
Den nya medicintekniska förordningen MDR har skapat en stor efterfrågan på konsulttjänster – en efterfrågan som ser ut att hålla i sig.
-
9 steps to perfect partnering
Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to ...
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.